USE OF COMPOUND DRUGS IN A NEONATAL INTENSIVE CARE UNIT

Authors

  • Isabel Rodrigues Calixto Linhares Hospital Municipal Maternidade Dr. Mário de Moraes Altenfelder Silva Endereço: Av. Dep. Emílio Carlos, 3100 - Vila Nova Cachoeirinha, São Paulo - SP, 02720-200
  • Clarice Yakabe Hospital Municipal Maternidade Dr. Mário de Moraes Altenfelder Silva Endereço: Av. Dep. Emílio Carlos, 3100 - Vila Nova Cachoeirinha, São Paulo - SP, 02720-200
  • Maria Fernanda Chiattone Hospital Municipal Maternidade Dr. Mário de Moraes Altenfelder Silva Endereço: Av. Dep. Emílio Carlos, 3100 - Vila Nova Cachoeirinha, São Paulo - SP, 02720-200
  • Marcia Eugenia Del Llano Archondo Universidade Santo Amaro Endereço: Rua Isabel Schmidt, 349 - Santo Amaro, São Paulo - SP, 04743-030

DOI:

https://doi.org/10.14450/2318-9312.v34.e2.a2022.pp139-145

Keywords:

compounding, neonatal ICU, hospital pharmacy

Abstract

The prescription of compounding can bring many therapeutic advantages, especially in specific areas such as neonatology, due to the low availability of the ideal pharmaceutical form for the clinical issues presented by these patients. This study aimed to analyze the prescription of oral compounding in a Neonatal Intensive Care Unit (NICU) in a tertiary-level Neonatology Hospital in São Paulo. A quantitative, descriptive, and retrospective study was carried out from March 2020 to February 2021, analyzing the frequencies of prescription drugs and therapeutic classes. The most compounding drugs as liquid formulations were spironolactone (31.7%), hydrochlorothiazide (17.9%), furosemide (14.2%), sildenafil (14.0%),  captopril (10.5%), omeprazole (9.7%) and propranolol (2.0%). According to the Anatomical Therapeutic Chemical (ATC) classification system, the largest prescriptions correspond to group C, cardiovascular diseases. The study shows the importance of compounding in the NICU and, therefore, the importance of hospital compounding in neonatology, ensuring the effectiveness and safety of medications.

Downloads

Published

2022-07-01

How to Cite

Rodrigues Calixto Linhares, I., Yakabe, C., Chiattone, M. F., & Del Llano Archondo, M. E. (2022). USE OF COMPOUND DRUGS IN A NEONATAL INTENSIVE CARE UNIT. Infarma - Pharmaceutical Sciences, 34(2), 139–145. https://doi.org/10.14450/2318-9312.v34.e2.a2022.pp139-145

Issue

Vol. 34 No. 2 (2022)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).